Mesalamine
NDC 67877-717, Mesalamine, capsule, extended release, from Ascend Laboratories, LLC.
- Product NDC
- 67877-717
- Status
- Listed
- Labeler
- Ascend Laboratories, LLC
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214242
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67877-717 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MESALAMINE.375 g/1
Pharmacologic classes
Aminosalicylate [EPC]; Aminosalicylic Acids [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67877-717-05 | 67877071705 | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (67877-717-05) |
| 67877-717-12 | 67877071712 | 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (67877-717-12) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/43f69db3-81ac-4da4-a61f-fbba6299d9c2NADAC price for package 67877071712
GET /v1/drugs/nadac/67877071712
Use it
Look up 67877-717 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67877-717 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67877-717. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.